Table 1.
Characteristics of the studies.
Table 2.
Definitions of the study endpoint.
Fig 1.
Forest plot with OR of prolonged-DAPT relative to short-DAPT for each clinical outcome for the DAPT trial and the pooled population excluding the DAPT trial.
ORs are shown on a logarithmic scale. CI = confidence interval, DAPT = dual anti-platelet therapy, and OR = odds ratio.
Fig 2.
Estimated annual event rates for myocardial infarction and stent thrombosis in the short-DAPT group during aspirin mono-therapy.
The landmark data was not available for myocardial infarction in the RESET and EXCELLENT trials. NA = not available.
Table 3.
Annual event rate on each randomized regimen.